Obesity treatment is entering a transformative era — and few therapies have garnered more attention or raised more questions than GLP-1 receptor agonists. In a featured session at Becker’s Fall 2025 Payer Issues Roundtable, Lia Gass Rodriguez, MD, chief medical officer at CVS Healthspire Payor Solutions, explored the complex terrain of GLP-1 drugs, outlining a […]
